Nested Therapeutics
PrivateLast Round
Series A
Oct 6, 2022
Total Funding Raised
$125M
Company Overview
Nested Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in October 2022.
Nested Therapeutics is a biotechnology company that develops precision oncology therapies by identifying new driver mutations and creating targeted small-molecule medications through advanced genomic and computational techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nested Therapeutics Comparables
Compare Nested Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TRIANA Biomedicines | 83% | |
| Erasca | 83% | |
| Neomorph | 81% |
For institutional investors. Book with your work email.
Nested Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2022 | ||||
| Seed | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nested Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Avidity Partners Management | Series A |
| TD Securities | Series A |
| Blue Owl Capital | Series A |
| Goldman Sachs Asset Management Private Equity | Series A |
| Avidity Partners | Series A |
| Foresite Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2022
$35M round led by Versant Ventures.
- Oct 6, 2022
$90M round led by Goldman Sachs Asset Management.
For institutional investors. Book with your work email.
Nested Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nested Therapeutics's valuation, stock price, and market status.
Is Nested Therapeutics a public or private company?
Nested Therapeutics is a private company.
What is the current stock price of Nested Therapeutics?
Nested Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nested Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nested Therapeutics worth (valuation)?
Valuation information for Nested Therapeutics is not publicly available.
Can I buy Nested Therapeutics stock?
Nested Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nested Therapeutics's last funding round?
Nested Therapeutics's most recent funding round was Series A on October 6, 2022.
Who are the main investors in Nested Therapeutics?
Key investors in Nested Therapeutics include Goldman Sachs Asset Management Private Equity, Versant Ventures.
Will Nested Therapeutics IPO soon?
No public IPO plans have been announced for Nested Therapeutics.
How can I track Nested Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nested Therapeutics's shares on secondary markets.